Table 1. Baseline characteristics.
| Variable | All (n = 2,035) |
MACE |
p value | |
|---|---|---|---|---|
| YES (n = 243) | NO (n = 1,792) | |||
| Age (years) | 65 ± 12 | 69 ± 9 | 65 ± 13 | < 0.001 |
| Men | 1,253 (62 %) | 187 (77 %) | 1,066 (59 %) | < 0.001 |
| Hypertension | 1,459 (72 %) | 220 (91 %) | 1,239 (69 %) | < 0.001 |
| Diabetes | 841 (41 %) | 138 (57 %) | 703 (39 %) | < 0.001 |
| Smoking | 1,122 (55 %) | 196 (81 %) | 926 (52 %) | < 0.001 |
| Total cholesterol (mg/dL) | 192 ± 42 | 180 ± 40 | 194 ± 42 | < 0.001 |
| Low-density lipoprotein cholesterol (mg/dL) | 115 ± 36 | 108 ± 34 | 116 ± 37 | 0.004 |
| High-density lipoprotein cholesterol (mg/dL) | 52 ± 16 | 46 ± 13 | 53 ± 16 | < 0.001 |
| Triglyceride (mg/dL) | 106 [75–154] | 108 [75.156] | 106 [73–154] | 0.79 |
| Anti-platelet therapy | 1,983 (97 %) | 241 (99 %) | 1,742 (97 %) | 0.142 |
| Lipid-lowering therapy | 1,846 (91 %) | 236 (97 %) | 1,610 (90 %) | < 0.001 |
| Carotid IMT (mm) | 0.8 [0.7–1.0] | 1.0 [0.8–1.1] | 0.8 [0.7–1.0] | < 0.001 |
| Carotid plaque score | 7.4 [3.4–12.3] | 12.2 [8.0–16.5] | 6.8 [3.1–11.4] | < 0.001 |
MACE: major adverse cardiac events, IMT: intima-media thickness